Global Protein Binding Assays Market – Industry Trends and Forecast to 2026

  • Healthcare
  • Upcoming Report
  • Jun 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Protein Binding Assays Market By Technology (Equilibrium Dialysis, Affinity Electrophoresis, Ultrafiltration, Ultracentrifugation, Surface Plasmon Resonance, Others), Product & Services (Instrument, Kits & Reagents, Services), End-Users (Pharmaceutical & Biotechnology Companies, CROs, Consulting Firms, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Protein Binding Assays Market

Global protein binding assays market is expected to rise to an estimated value of USD 630.00 million by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the growing volume of contract research organizations globally and the increasing applications of these compounds for development and discovery of drugs for the pharmaceutical industry.

Market Definition: Global Protein Binding Assays Market

Protein binding assays are compounds which are used for the manufacturing of various pharmaceuticals as they are able to identify and provide researchers & scientists with invaluable information for the reactions between molecules. They also provide insights into the concentration of proteins present during a specific reaction between molecules. This information is important due to the detection of effects that protein will have on the consumer of pharmaceuticals being developed consisting of these proteins.

Market Drivers

  • Focus on curbing the expenditure being incurred on the drug discovery and their manufacturing; this factor is expected to propel the growth of the market
  • Availability of various advanced technologies utilized for protein binding; this factor will drive the market growth
  • Increasing volume of expenditure carried out for advancing the technologies available for development of pharmaceuticals will also boost the market growth
  • Increasing incidences of drug failures during the latter stages giving rise to usage of better components and understanding of pharmaceutical development acts as a market driver

Market Restraints

  • Concerns regarding various complications associated with technology available which is to be used in combination with these products is expected to hinder the growth of the market
  • Dearth of information and skills associated with utilization of protein binding assays globally; is another factor restricting this market growth
  • Complicated nature of standards present for the designing and development of assays will also impede the market growth

Segmentation: Global Protein Binding Assays Market

By Technology

  • Equilibrium Dialysis
  • Affinity Electrophoresis
  • Ultrafiltration
  • Ultracentrifugation
  • Surface Plasmon Resonance
  • Others

By Product & Services

  • Instrument
  • Kits & Reagents
  • Services

By End-Users

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Consulting Firms
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In November 2017, Promega Corporation announced the availability of “NanoBRET Target Engagement (TE) Intracellular Kinase Assay” which is the first available in the industry which can help in the quantification of inhibitor drugs binding with kinase proteins present inside live human cells. This assay is an advanced technology available for the identification of potency of kinase inhibitors in live cells
  • In March 2017, 3B Pharmaceuticals GmbH along with Sovicell GmbH announced the availability of a service designed for quantification of plasma protein binding capabilities of experimental drugs. “EScalate” is based on Sovicell’s proprietary equilibrium shift technology and this service will exclusively be provided by 3B Pharmaceuticals GmbH along with Sovicell’s reagents

Competitive Analysis:

Global protein binding assays market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of protein binding assays market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global protein binding assays market are Merck KGaA; Thermo Fisher Scientific Inc.; GENERAL ELECTRIC COMPANY; Sovicell GmbH; Absorption Systems LLC; Cyprotex; Bioduro; Eurofins Scientific; ADMEcell, Inc.; 3B Pharmaceuticals; Biotium; Beckman Coulter, Inc.; Sartorius Stedim BioOutsource Limited; Bio-Rad Laboratories, Inc.; nanoComposix; Abzena Ltd; Abcam plc; GVK Biosciences Private Limited; Promega Corporation; Arrayit Corporation among others.

Research Methodology: Global Protein Binding Assays Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global protein binding assays market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19